Xarelto Bleeding Lawsuits
Rivaroxaban, marketed by Bayer under the brand name Xarelto, is a popular oral prescription blood-thinning drug. Since its U.S. Food and Drug Administration (FDA) approval in 2011, sales of the drug have totaled more than $320 million. Yet, despite its success, Xarelto has been shown to increase the risks of serious bleeding, stroke, and blood clots among certain types of patients.
Ferrer, Poirot & Wansbrough can help if you or a loved one took Xarelto and suffered from severe bleeding, stroke, or a blood clot. We have more than 35 years of experience helping drug injury victims get the compensation they need, and we want to help you, too. Contact us 24 hours a day, seven days a week—just dial (800) 210-8503 or fill out a free initial consultation form.
Xarelto Side Effect Risks
Researchers have linked Xarelto to an increased risk of bleeding among patients who:
Patients with acute medical illnesses who take Xarelto face a nearly three-fold increase in the risk of major bleeding.
Suffer from Acute Coronary Syndrome (ACS)
Xarelto more than triples the risk of major bleeding among patients suffering from ACS.
The risk of severe bleeding is doubled among hip surgery patients who take Xarelto.
Unlike older blood-thinning drugs like warfarin (Coumadin®), there’s no counteracting drug to reverse the effects of Xarelto. This may increase patients’ risk of severe injury or death in the event of major bleeding.
The Legal Help You Deserve
You don’t have to pay for a drug company’s negligence. At Ferrer, Poirot & Wansbrough, we’ve recovered hundreds of millions of dollars* for our clients nationwide. If you or a loved one suffered a stroke, severe bleeding, or a blood clot after taking Xarelto, we want to protect your rights. Contact us today to get the help you need.
Coumadin® is a registered trademark of Bristol-Myers Squibb Company and is used here only for the purpose of identifying the product in question. Xarelto® is a registered trademark of Bayer AG and is used here only for the purpose of identifying the product in question.
This law firm is not associated with, sponsored by, or affiliated with Bayer AG; Bristol-Myers Squibb Company; the National Center for Biotechnology Information; the New York Medical College-Metropolitan Hospital Center; the U.S. Food and Drug Administration; or the U.S. National Library of Medicine.
*Zyprexa, Seroquel, and Avandia gross settlements; attorney fees and expenses deducted.